Related Experiment Video
Updated: Oct 25, 2025

08:57
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
27.3K
Remyelination Trials: Are We Expecting the Unexpected?
Alexandr Klistorner1, Michael Barnett2
1From the Sydney University (A.K., M.B.); Maquarie University (A.K.); and Sydney Neuroimaging Analysis Center (M.B.), Australia. sasha@eye.usyd.edu.au.
Neurology(R) Neuroimmunology & Neuroinflammation
|August 11, 2021
Summary
Remyelination shows promise for multiple sclerosis (MS) neuroprotection. This review examines challenges in remyelination trials, offering design guidance and managing expectations for researchers and industry.
Area of Science:
- Neuroscience
- Neurology
- Clinical Trials
Background:
- Multiple sclerosis (MS) is characterized by progressive neuroaxonal loss, leading to disability.
- Acute axonal damage occurs during inflammatory demyelination, while chronic loss of demyelinated axons contributes to progressive damage.
- Remyelination is a potential neuroprotective strategy for MS.
Purpose of the Study:
- To review potential pitfalls in clinical trials for remyelination therapies in MS.
- To provide a framework for designing effective remyelination trials.
- To manage expectations regarding the outcomes of remyelination research.
Main Methods:
- Literature review of existing remyelination trials and research.
- Analysis of common challenges and limitations in trial design.
- Development of recommendations for future trial frameworks.
Main Results:
- Identified key challenges in remyelination trial design and execution.
- Proposed a structured approach for optimizing trial methodologies.
- Highlighted the need for realistic outcome assessments.
Conclusions:
- Careful trial design is crucial for evaluating remyelination efficacy in MS.
- Managing expectations is essential for researchers, regulators, and the pharmaceutical industry.
- Optimized trials will better determine the neuroprotective potential of remyelination in MS.

